Intensity Therapeutics (INTS) Return on Assets (2023 - 2026)

Intensity Therapeutics (INTS) has 4 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Assets rose 3.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 3.0% YoY) and the FY2025 annual result came in at 0.01%, up 2.0% from the prior year.
• Return on Assets advanced to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2023 to a low of 0.04% in Q1 2025.
• A 4-year average of 0.02% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2024 — Return on Assets fell 3 bps — and 2026, when it increased 3 bps.
• Tracing INTS's Return on Assets over 4 years: stood at 0.01% in 2023, then slumped by 543 bps to 0.03% in 2024, then jumped by 69 bps to 0.01% in 2025, then climbed by 17 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.